Mapping of the funding flows associated with the introduction of CAR-T treatments for DLBCL in the Chinese healthcare system

Goal

CAR-T therapies face payer restrictions and access challenges due to their high cost and associated procedures. Our client needed to understand the CAR-T hospital funding flows in China to identify barriers and maximize access opportunities.

Approach

Draft anticipated CAR-T funding flows

… for the target indications via desk research and leveraging internal knowledge

In-depth interviews with local experts

(e.g. prescribers, hospital managers) to validate funding flows and identify gaps and opportunities

Generation of initiatives

Come up with a solid plan for action

Ideated strategies included:

Risk-benefit ratio analysis of public listing
Initial launch in the private market
Innovative MEAs offerings
Patient-support programs

The challenge: Bridge knowledge gaps in China

Contact our experts

Philippe Coune

Partner

Miliyun Chiu

Senior Consultant

Charlotte Ng

Senior Consultant

Yin Sing Ng

Senior Consultant

Learn more about our China CoE

Our China Center of Excellence

We use cookies to ensure we give you the best experience on our website. Detailed information on the use of cookies, and how you can disable them, is provided in our Privacy Policy. By using this site or clicking on "OK", you consent to the use of cookies.